• 1
    Mueller U, Mosbech H. EAACI position paper: Immunotherapy with Hymenoptera venoms. Allergy 1993;48: S37S46.
  • 2
    Mosbech H, Mueller U. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. Allergy 2000;55: 10051010.
  • 3
    Brehler R, Wolf H, Kutting B, Schnitker J, Luger T. Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 2000;105: 12311235.
  • 4
    Sturm G, Kranke B, Rudolph C, Aberer W. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110: 928933.
  • 5
    Birnbaum J, Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy 2003;33: 5864.
  • 6
    Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003;33: 12161220.
  • 7
    Rueff F, Przybilla B. Ultrarush immunotherapy in patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2001;107: 928929.
  • 8
    Quercia O, Rafanelli S, Puccinelli P, Stefanini GF. The safety of cluster immunotherapy with aluminium hydroxide-adsorbed honey bee venom extract. J Investig Allergol Clin Immunol 2001;11: 2733.
  • 9
    Rueff F, Wolf H, Schnitker J, Ring J, Przybilla B. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy 2004;59: 589595.
  • 10
    Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997;100: 458463.
  • 11
    Reimers A, Hari Y, Muller U. Reduction of side-effects from ultrarush immunotherapy with honey bee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 2000;55: 484488.
  • 12
    Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001;357: 361362.
  • 13
    Sturm GJ, Bohm E, Trummer M, Weiglhofer I, Heinemann A, Aberer W. The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy 2004;59: 11101117.
  • 14
    Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88: 328338.
  • 15
    Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000;30: 11661171.
  • 16
    Erdmann SM, Sachs B, Kwiecien R, Moll-Slodowy S, Sauer I, Merk HF. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy. Allergy 2004;59: 11021109.
  • 17
    Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110: 341348.
  • 18
    Mueller U. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart, New York, USA: Gustav Fischer Verlag, 1990.
  • 19
    Sainte-Laudy J, Vallon C, Guerin JC. Diagnosis of latex allergy: comparison of histamine release and flow cytometric analysis of basophil activation. Inflamm Res 1996;45: S3536
  • 20
    MacGlashan D Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993;91: 605615.
  • 21
    MacGlashan D Jr. Two regions of down-regulation in the IgE-mediated signalling pathway in human basophils. J Immunol 2003;170: 49144925.
  • 22
    Siegmund R, Vogelsang H, Machnik A, Herrmann D. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol 2000;106: 11901195.
  • 23
    Hemmer W, Focke M, Kolarich D, Wilson IB, Altmann F, Wohrl S et al. Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J Allergy Clin Immunol 2001;108: 10451052.
  • 24
    Kosnik M, Korosec P, Silar M, Music E, Erzen R. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting. Croat Med J 2002;43: 2527.